Grifols News, Grifols Quote, GRFS Quote

Grifols (NQ:GRFS) Delayed: 7.61 --0 (-0%)

Prev. Close

$7.61

Today 6M 1Y 5Y

Open

$7.61

52 Wk High

$35.35

52 Wk Low

$14.07

Day High

$7.61

Day Low

$7.61

P/E

N/A

EPS

$0.00

Volume

269

Friends, Peers and Foes (?): 0RDU, GRF, GRF-P GIKLY (more...)

ALERTS | RSS

Jul 16, 2026 08:01 AM Grifols starts two Phase 3 trials to expand immunoglobulin labels
Jul 16, 2026 08:00 AM Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins
Jun 22, 2026 02:18 PM Form 6-K Grifols SA For: Jun 22
Jun 18, 2026 04:00 PM Form 6-K Grifols SA For: Jun 18
Jun 15, 2026 08:02 AM Grifols launches FESILTY fibrinogen concentrate in the US
Jun 15, 2026 08:00 AM Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.
May 15, 2026 01:14 PM Form 6-K Grifols SA For: May 15
May 14, 2026 04:06 PM Form SCHEDULE 13G/A Grifols SA Filed by: BRANDES INVESTMENT PARTNERS, LP
May 7, 2026 02:36 PM Form 6-K Grifols SA For: May 07
Apr 17, 2026 04:13 PM Form 20-F Grifols SA For: Dec 31

Entities mentioned with GRFS

View All Entities